Search research articles
Contact Us
Filters
Showing results (11-20 of 263) with videos related to
Page
of 27
Sort By:
Gastroenterology
|
April 28, 2023
Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology
Josep M Llovet, Mathias Heikenwalder
Hepatology (Baltimore, Md.)
|
January 13, 2022
T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
Pierluigi Ramadori, Shing Kam, Mathias Heikenwalder
Swiss Medical Weekly
|
October 25, 2011
The parallel universe: microRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis
Johannes Haybaeck, Nicolas Zeller, Mathias Heikenwalder
The Journal of Clinical Investigation
|
July 16, 2004
Progress and problems in the biology, diagnostics, and therapeutics of prion diseases
Adriano Aguzzi, Mathias Heikenwalder, Gino Miele
Endocrine, Metabolic & Immune Disorders Drug Targets
|
March 17, 2015
CCL2-CCR2 Signaling in Disease Pathogenesis
Tracy O'Connor, Lubor Borsig, Mathias Heikenwalder
Nature Metabolism
|
September 27, 2025
Shooting for the stars: caspase-8-meteorin in MASH and fibrosis
Suchira Gallage, Tabea Bieler, Mathias Heikenwalder
Digestive Diseases (Basel, Switzerland)
|
June 26, 2013
Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development
Marc Ringelhan, Mathias Heikenwalder, Ulrike Protzer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2015
Next Generation of Preclinical Liver Cancer Models
Achim Weber, Tracy O'Connor, Mathias Heikenwalder
Nature Reviews. Molecular Cell Biology
|
June 23, 2007
Insights into prion strains and neurotoxicity
Adriano Aguzzi, Mathias Heikenwalder, Magdalini Polymenidou
FEBS Letters
|
June 17, 2009
Cells and prions: a license to replicate
Mario Nuvolone, Adriano Aguzzi, Mathias Heikenwalder
Page
of 27
Search research articles
Search
Showing results (11-20 of 263) with videos related to
Sort By:
Page
of 27
Gastroenterology
|
April 28, 2023
Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology
Josep M Llovet, Mathias Heikenwalder
Hepatology (Baltimore, Md.)
|
January 13, 2022
T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
Pierluigi Ramadori, Shing Kam, Mathias Heikenwalder
Swiss Medical Weekly
|
October 25, 2011
The parallel universe: microRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis
Johannes Haybaeck, Nicolas Zeller, Mathias Heikenwalder
The Journal of Clinical Investigation
|
July 16, 2004
Progress and problems in the biology, diagnostics, and therapeutics of prion diseases
Adriano Aguzzi, Mathias Heikenwalder, Gino Miele
Endocrine, Metabolic & Immune Disorders Drug Targets
|
March 17, 2015
CCL2-CCR2 Signaling in Disease Pathogenesis
Tracy O'Connor, Lubor Borsig, Mathias Heikenwalder
Nature Metabolism
|
September 27, 2025
Shooting for the stars: caspase-8-meteorin in MASH and fibrosis
Suchira Gallage, Tabea Bieler, Mathias Heikenwalder
Digestive Diseases (Basel, Switzerland)
|
June 26, 2013
Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development
Marc Ringelhan, Mathias Heikenwalder, Ulrike Protzer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2015
Next Generation of Preclinical Liver Cancer Models
Achim Weber, Tracy O'Connor, Mathias Heikenwalder
Nature Reviews. Molecular Cell Biology
|
June 23, 2007
Insights into prion strains and neurotoxicity
Adriano Aguzzi, Mathias Heikenwalder, Magdalini Polymenidou
FEBS Letters
|
June 17, 2009
Cells and prions: a license to replicate
Mario Nuvolone, Adriano Aguzzi, Mathias Heikenwalder
Page
of 27